当前位置:首页 - 行情中心 - 创新医疗(002173) - 财务分析 - 现金流量表

创新医疗

(002173)

  

流通市值:75.29亿  总市值:78.95亿
流通股本:4.21亿   总股本:4.41亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金368,028,720.69172,529,659.37832,594,822.01638,403,885.18
  收到的税费返还160,904.29---
  收到其他与经营活动有关的现金6,240,094.6114,046,606.1618,272,545.084,910,503.52
  经营活动现金流入小计374,429,719.59186,576,265.53850,867,367.09643,314,388.7
  购买商品、接受劳务支付的现金166,149,303.2361,569,407.53365,217,232.98259,267,653.79
  支付给职工以及为职工支付的现金174,860,226.4892,897,934.23348,206,267.61263,178,301.43
  支付的各项税费10,993,314.437,544,536.3115,140,820.5213,167,251.1
  支付其他与经营活动有关的现金24,912,897.2428,066,186.1246,372,884.4735,976,974.85
  经营活动现金流出小计376,915,741.38190,078,064.19774,937,205.58571,590,181.17
  经营活动产生的现金流量净额-2,486,021.79-3,501,798.6675,930,161.5171,724,207.53
二、投资活动产生的现金流量:
  收回投资收到的现金186,347,018.28-208,036,380.9376,776,006.26
  处置固定资产、无形资产和其他长期资产收回的现金净额193,129.08-96,801.8490,625.66
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计186,540,147.36-208,133,182.7776,866,631.92
  购建固定资产、无形资产和其他长期资产支付的现金10,097,443.415,719,340.484,519,356.3152,757,041.65
  投资支付的现金135,901,787.45,798,579.77120,100,000-
  取得子公司及其他营业单位支付的现金--1,066,405.351,066,405.35
  投资活动现金流出小计145,999,230.8111,517,920.17205,685,761.6653,823,447
  投资活动产生的现金流量净额40,540,916.55-11,517,920.172,447,421.1123,043,184.92
三、筹资活动产生的现金流量:
  取得借款收到的现金45,000,00015,000,00018,000,00018,000,000
  收到其他与筹资活动有关的现金-44,447.225,006,676.09351,000
  筹资活动现金流入小计45,000,00015,044,447.2223,006,676.0918,351,000
  偿还债务支付的现金10,000,00010,000,00015,800,00015,800,000
  分配股利、利润或偿付利息支付的现金1,350,864.71650,552.962,590,902.292,029,613.52
  支付其他与筹资活动有关的现金57,165,407.642,437,043.0613,705,415.659,965,776.3
  筹资活动现金流出小计68,516,272.3513,087,596.0232,096,317.9427,795,389.82
  筹资活动产生的现金流量净额-23,516,272.351,956,851.2-9,089,641.85-9,444,389.82
五、现金及现金等价物净增加额14,538,622.41-13,062,867.6369,287,940.7785,323,002.63
  加:期初现金及现金等价物余额186,791,374.21186,791,374.21117,503,433.44117,503,433.44
  期末现金及现金等价物余额201,329,996.62173,728,506.58186,791,374.21202,826,436.07
补充资料:
  净利润-54,698,244.55--36,255,305.06-
  资产减值准备-1,695,658.64--2,803,942.52-
  固定资产和投资性房地产折旧40,060,948.39-78,882,995.24-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧40,060,948.39-78,882,995.24-
  无形资产摊销4,943,025.43-7,994,895.71-
  长期待摊费用摊销3,622,350.53-7,030,892.6-
  处置固定资产、无形资产和其他长期资产的损失-25,803.11--15,644.3-
  固定资产报废损失352,560.11-1,922,725.11-
  公允价值变动损失-1,025,434.25--4,772,921.17-
  财务费用2,059,760.45-3,815,098.77-
  投资损失-535,968.55--32,155,570.61-
  递延所得税41,014.88-6,544,924.45-
  其中:递延所得税资产减少780,021.95-7,388,647.83-
    递延所得税负债增加-739,007.07--843,723.38-
  存货的减少15,717,776.37-5,934,116.66-
  经营性应收项目的减少19,064,899.45-38,997,299.14-
  经营性应付项目的增加-31,506,878.43--10,814,318.95-
  其他-2,898,083.99-2,536,585.32-
  融资租入固定资产--12,908,562.57-
  现金的期末余额201,329,996.62-186,791,374.21-
  减:现金的期初余额186,791,374.21-117,503,433.44-
  现金及现金等价物的净增加额14,538,622.41-69,287,940.77-
公告日期2026-08-152026-04-302026-04-252025-10-25
审计意见(境内)标准无保留意见
TOP↑